BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33859351)

  • 1. DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway.
    Im JY; Kim BK; Yoon SH; Cho BC; Baek YM; Kang MJ; Kim N; Gong YD; Won M
    Exp Mol Med; 2021 Apr; 53(4):643-653. PubMed ID: 33859351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miconazole inhibits signal transducer and activator of transcription 3 signaling by preventing its interaction with DNA damage-induced apoptosis suppressor.
    Yoon SH; Kim BK; Kang MJ; Im JY; Won M
    Cancer Sci; 2020 Jul; 111(7):2499-2507. PubMed ID: 32476221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage-induced apoptosis suppressor (DDIAS), a novel target of NFATc1, is associated with cisplatin resistance in lung cancer.
    Im JY; Lee KW; Won KJ; Kim BK; Ban HS; Yoon SH; Lee YJ; Kim YJ; Song KB; Won M
    Biochim Biophys Acta; 2016 Jan; 1863(1):40-9. PubMed ID: 26493727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of the cancer target DDIAS is regulated by the CHIP/HSP70 pathway in lung cancer cells.
    Won KJ; Im JY; Kim BK; Ban HS; Jung YJ; Jung KE; Won M
    Cell Death Dis; 2017 Jan; 8(1):e2554. PubMed ID: 28079882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
    Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis.
    Yang F; Jove V; Buettner R; Xin H; Wu J; Wang Y; Nam S; Xu Y; Ara T; DeClerck YA; Seeger R; Yu H; Jove R
    Cancer Biol Ther; 2012 May; 13(7):534-41. PubMed ID: 22406995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.
    Im JY; Kim BK; Lee JY; Park SH; Ban HS; Jung KE; Won M
    Oncogene; 2018 Mar; 37(9):1251-1262. PubMed ID: 29242605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
    Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
    Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
    Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance.
    Zheng Q; Dong H; Mo J; Zhang Y; Huang J; Ouyang S; Shi S; Zhu K; Qu X; Hu W; Liu P; Wang Y; Zhang X
    Theranostics; 2021; 11(2):824-840. PubMed ID: 33391507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDIAS promotes STAT3 activation by preventing STAT3 recruitment to PTPRM in lung cancer cells.
    Im JY; Kim BK; Lee KW; Chun SY; Kang MJ; Won M
    Oncogenesis; 2020 Jan; 9(1):1. PubMed ID: 31900385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways.
    Yang F; Jove V; Xin H; Hedvat M; Van Meter TE; Yu H
    Mol Cancer Res; 2010 Jan; 8(1):35-45. PubMed ID: 20053726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells.
    Siveen KS; Nguyen AH; Lee JH; Li F; Singh SS; Kumar AP; Low G; Jha S; Tergaonkar V; Ahn KS; Sethi G
    Br J Cancer; 2014 Sep; 111(7):1327-37. PubMed ID: 25101566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3.
    Shou J; You L; Yao J; Xie J; Jing J; Jing Z; Jiang L; Sui X; Pan H; Han W
    Cancer Lett; 2016 Aug; 379(1):124-33. PubMed ID: 27264264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of Raddeanin A is mediated by Jun amino-terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma.
    Wang Z; Shen J; Sun W; Zhang T; Zuo D; Wang H; Wang G; Xu J; Yin F; Mao M; Zhou Z; Hua Y; Cai Z
    Cancer Sci; 2019 May; 110(5):1746-1759. PubMed ID: 30907478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.